Navigation Links
International Scientific Workshop Focuses on New Methods for Vaccine and Antibody Development
Date:9/12/2007

NEWARK, Del., Sept. 12 /PRNewswire-USNewswire/ -- Leading scientists from around the world will meet in Wilmington, Delaware next week to discuss innovative approaches for producing life-saving vaccines and antibodies. More than 125 scientists and business leaders will be participating in "New Cells for New Vaccines II: Focus on Respiratory Virus Diseases" on September 17-19 at the Hotel du Pont. The international scientific workshop is being organized by the Fraunhofer USA Center for Molecular Biotechnology (CMB) and InB:Biotechnologies, Inc. of Newark, Delaware, under the auspices of the International Association for Biologicals (IABS).

According to Dr. Vidadi Yusibov, Executive Director of the Fraunhofer USA Center for Molecular Biotechnology, "The past fifty years have seen an increase in the types of cells that can be used for vaccine and antibody production, however, there remains a need for new cell substrates that can provide safer, faster and more cost effective production alternatives to current techniques, especially with the potential threat of an influenza pandemic."

"A key aspect of the success and viability of a vaccine development project is the choice of an appropriate cell substrate," said Dr. Geoffrey Schild, Chief Scientific Officer of InB:Biotechnologies and a Director of IABS. "The advantages of plant, animal and insect cell systems are increasingly being recognized and many projects are in progress internationally, including development of respiratory virus, cervical cancer, anthrax and malaria vaccines, as well as therapeutic antibodies to treat influenza infections."

New Cells for New Vaccines II: Focus on Respiratory Virus Diseases will be of interest to scientists and business leaders in the biotechnology and pharmaceutical industry involved in vaccine development and production, as well as public health officials, medical and veterinary experts. More details and registration information are available on the meeting web site (http://www.NewCellsforNewVaccines.com).

About Fraunhofer USA Center for Molecular Biotechnology:

The mission of Fraunhofer USA CMB is to develop safe and effective vaccines targeting infectious diseases and autoimmune disorders. CMB's technology provides a safe, rapid and economical alternative for vaccine production. Fraunhofer USA CMB is part of Fraunhofer USA, Inc., a non-profit research and development corporation, with headquarters in Michigan. It operates through technology centers that are partnered with major research universities in the United States and also with parent research institutes in Germany.

For more information, contact: Dale Ervin, Fraunhofer USA CMB at 302-369-1708 or dervin@fraunhofer-cmb.org.


'/>"/>
SOURCE Fraunhofer USA
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Olympics of biotechnology has international flavor
2. Traffic data firm navigates international business
3. Catalyst International profit exceeds expectations
4. Lack of broadband hamstrings international videoconferencing
5. 30 days to success: Three simple steps to create your own international startup
6. TEKLYNX International announces new RFID software
7. Ruling enforces international trademark electronic filing requirements
8. Eleftheriou to lead Catalyst International
9. Internet trademark war goes international
10. International eyes drawn to Madisons games research
11. Plexus and SRI International team up to offer medical product development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... clearance to begin marketing the SPEAC® System, the Brain Sentinel® Seizure Monitoring and ... or in healthcare facilities during periods of rest. A lightweight, non-invasive monitor is ...
(Date:2/23/2017)... ... 23, 2017 , ... The Greater Gift Initiative, Inc , (GGI) a ... Research . GGI's mission is to advance global health and highlight the greater good ... honor of each clinical trial volunteer. The vision of GGI is to serve as ...
(Date:2/23/2017)... ... February 22, 2017 , ... ... have been named Fellows of the Society this year, the Fellows Committee has ... multidisciplinary fields of optics, photonics, and imaging as well as their service to ...
(Date:2/22/2017)... , Feb. 22, 2017  PrimeVax Immuno-Oncology, Inc. ... be presenting at the Annual Biocom Global Life Science ... 2, at 11:15 AM, at the Torrey Pines Lodge, ... to the organizers at Biocom who have chosen our ... symposium of biotechnology companies, investors, and clinical researchers," said ...
Breaking Biology Technology:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a ... announced that it has received Laboratory Accreditation from ... Accreditation is presented to laboratories that meet stringent ... demonstrate scientifically rigorous processes. "Genos is ... in laboratory practices. We,re honored to be receiving ...
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
(Date:2/8/2017)... , Feb. 8, 2017 About Voice Recognition ... to match it against a stored voiceprint template. ... pitch, cadence, and tone are compared to distinguish ... hardware installation, as most PCs already have a ... transactions. Voice recognition biometrics are most likely to ...
Breaking Biology News(10 mins):